PARATEK PHARMACEUTICALS INC filings

All
Holdings
Significant ownership
Insider transactions
Annual reports
Quarterly reports
Events
Shareholder votes
SEC filings by PARATEK PHARMACEUTICALS INC (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13G/A2016-07-11FMR LLCParatek Pharmaceuticals, Inc.2,115,2929.7%EDGAR
SC 13G/A2016-02-16Abingworth LLPParatek Pharmaceuticals, Inc.1,301,4137.4%EDGAR
SC 13G/A2016-02-12FMR LLCParatek Pharmaceuticals, Inc.2,641,29215.0%EDGAR
SC 13G/A2016-02-12BAUPOST GROUP LLC/MAParatek Pharmaceuticals, Inc.1,544,4988.8%EDGAR
SC 13G/A2015-02-17EcoR1 Capital, LLCParatek Pharmaceuticals, Inc.30,006-EDGAR
SC 13G2015-02-06Abingworth LLPParatek Pharmaceuticals, Inc.1,310,4829.1%EDGAR
SC 13G2014-12-11BAUPOST GROUP LLC/MAParatek Pharmaceuticals, Inc.1,735,21812.0%EDGAR
SC 13G2014-12-10FMR LLCParatek Pharmaceuticals, Inc.1,735,21812.0%EDGAR
SC 13D2014-11-13HBM Healthcare Investments (Cayman) Ltd.Paratek Pharmaceuticals, Inc.1,771,46212.3%EDGAR
SC 13D2014-11-10Omega Fund III, L.P.Paratek Pharmaceuticals, Inc.1,114,5257.1%EDGAR
SC 13G/A2014-11-10Roumell Asset Management, LLCParatek Pharmaceuticals, Inc.263,294-EDGAR
SC 13D/A2014-11-04New Enterprise Associates 12, Limited PartnershipParatek Pharmaceuticals, Inc.--EDGAR
SC 13D/A2014-11-04InterWest Partners IX, LPParatek Pharmaceuticals, Inc.512,3673.6%EDGAR
SC 13G2014-08-29EcoR1 Capital, LLCTranscept Pharmaceuticals Inc478,5142.5%EDGAR
SC 13G/A2014-08-26Prosight Fund, LPTranscept Pharmaceuticals Inc1,071,4295.6%EDGAR
SC 13D/A2014-07-14InterWest Partners IX, LPTranscept Pharmaceuticals Inc1,983,88410.5%EDGAR
SC 13G/A2014-02-04Roumell Asset Management, LLCTranscept Pharmaceuticals Inc2,171,651-EDGAR
SC 13G2013-12-18Roumell Asset Management, LLCTranscept Pharmaceuticals Inc2,182,991-EDGAR
SC 13D/A2013-12-16Roumell Asset Management, LLCTranscept Pharmaceuticals Inc--EDGAR
SC 13D/A2013-12-11SC Fundamental Value Fund, L.P.Transcept Pharmaceuticals Inc1,123,3816.0%EDGAR
External links